Research Areas

Integrated ADMETox platform aimed at easing preclinical bottleneck and lowering development attrition rates.

Welcome to the April issue of Drug Discovery News. Just eight short months after the termination announcement of Modern Drug Discovery, former MDD executives and editors present you with a unique and exclusive format for industry news.

It’s a crowded market for trade publications covering drug discovery. We know that. We also know that in order to stand out in a crowd you need to be different. With that, we introduce you to Drug Discovery News a trade publication that’s more like the business section of your daily newspaper, than any other publication covering drug discovery. This is no “me too” publication that is feature rich, technology-focused and light on news.

In a move that further broadens its offerings in bioinformatics software, Tripos Inc. closed its acquisition earlier this month for Austin, Texas-based Optive Research, a two-year old technology and software spinout of the University of Texas at Austin.

Funding boosts capital pool by $11.8 million and adds informatics expertise

With $100 million in its coffers, Amgen Ventures, a corporate venture capital fund initiated by Amgen Inc. in late 2004, will provide monetary assistance for emerging biotechnology companies that work in Amgen’s areas of interest related to human therapeu

After several months of discussions, GenoLogics Life Sciences Software Inc., based here, and Nonlinear Dynamics of Newcastle upon Tyne, England, have entered into a global partnership agreement that will result in an integrated protein informatics softwar

Bioinformatics News Briefs

With more than 1,800 proteins on its surface, the new product marks the debut of high-density protein microarrays

Chief Scientific Officer leads convergence of technology, science